Table 3.
Clinical data and pathogens of HAP (hospital-acquired pneumonia), VAP (ventilator-associated pneumonia and CAPA (COVID-19-associated pulmonary aspergillosis).
| HAP (n = 5) | VAP (n = 45) | CAPA (n = 9) | |
|---|---|---|---|
| Median time since detection (+/−SD) in days | |||
| Since symptom onset of COVID-19 infection | 15 (10.14) | 18 (10.69) | 21 (10.64) |
| Since hospital admission | 7 (7.4) | 8.5 (8.05) | 13.69 (8.67) |
| Since ICU admission | 5 (4.5) | 5 (4.75) | 10.6 (5.6) |
| Since intubation | N/A | 5.5 (4.24) | 8.15 (6.57) |
| Detected pathogens | 17.7% S. aureus 15.6% H. influenzae 11.1% K. pneumoniae 8.8% P. aeruginosa 6.7% S. maltophilia 4.4% E. coli 2.2% M. catarrhalis 33.5% polymicrobial |
||
| 25% MRSA | 44.4% A. fumigatus | ||
| 25% P. aeruginosa | 11.1% A. niger | ||
| 50% polymicrobial | 44.4% unknown |